These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
366 related articles for article (PubMed ID: 32211216)
21. Progress in brain targeting drug delivery system by nasal route. Khan AR; Liu M; Khan MW; Zhai G J Control Release; 2017 Dec; 268():364-389. PubMed ID: 28887135 [TBL] [Abstract][Full Text] [Related]
22. Recent patents review on intranasal administration for CNS drug delivery. Jogani V; Jinturkar K; Vyas T; Misra A Recent Pat Drug Deliv Formul; 2008; 2(1):25-40. PubMed ID: 19075895 [TBL] [Abstract][Full Text] [Related]
23. Intranasal delivery: circumventing the iron curtain to treat neurological disorders. Jiang Y; Li Y; Liu X Expert Opin Drug Deliv; 2015; 12(11):1717-25. PubMed ID: 26206202 [TBL] [Abstract][Full Text] [Related]
24. Nose-to-brain drug delivery for the treatment of CNS disease: New development and strategies. Du L; Chen L; Liu F; Wang W; Huang H Int Rev Neurobiol; 2023; 171():255-297. PubMed ID: 37783558 [TBL] [Abstract][Full Text] [Related]
25. Strategies for intranasal delivery of therapeutics for the prevention and treatment of neuroAIDS. Hanson LR; Frey WH J Neuroimmune Pharmacol; 2007 Mar; 2(1):81-6. PubMed ID: 18040829 [TBL] [Abstract][Full Text] [Related]
27. Drug delivery systems from nose to brain. Misra A; Kher G Curr Pharm Biotechnol; 2012 Sep; 13(12):2355-79. PubMed ID: 23016642 [TBL] [Abstract][Full Text] [Related]
28. Image guided biodistribution and pharmacokinetic studies of theranostics. Ding H; Wu F Theranostics; 2012; 2(11):1040-53. PubMed ID: 23227121 [TBL] [Abstract][Full Text] [Related]
29. Intranasal delivery to the central nervous system: mechanisms and experimental considerations. Dhuria SV; Hanson LR; Frey WH J Pharm Sci; 2010 Apr; 99(4):1654-73. PubMed ID: 19877171 [TBL] [Abstract][Full Text] [Related]
30. Improving brain drug targeting through exploitation of the nose-to-brain route: a physiological and pharmacokinetic perspective. Badhan RK; Kaur M; Lungare S; Obuobi S Curr Drug Deliv; 2014; 11(4):458-71. PubMed ID: 24655046 [TBL] [Abstract][Full Text] [Related]
31. Nose to brain delivery of antiretroviral drugs in the treatment of neuroAIDS. Sarma A; Das MK Mol Biomed; 2020; 1(1):15. PubMed ID: 34765998 [TBL] [Abstract][Full Text] [Related]
32. Stimuli-responsive In situ gelling system for nose-to-brain drug delivery. Agrawal M; Saraf S; Saraf S; Dubey SK; Puri A; Gupta U; Kesharwani P; Ravichandiran V; Kumar P; Naidu VGM; Murty US; Ajazuddin ; Alexander A J Control Release; 2020 Nov; 327():235-265. PubMed ID: 32739524 [TBL] [Abstract][Full Text] [Related]
34. Multimodality imaging of nanoparticle-based vaccines: Shedding light on immunology. Younis MH; Tang Z; Cai W Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2022 Sep; 14(5):e1807. PubMed ID: 35501142 [TBL] [Abstract][Full Text] [Related]
35. In vitro and ex vivo experimental models for evaluation of intranasal systemic drug delivery as well as direct nose-to-brain drug delivery. Haasbroek-Pheiffer A; Van Niekerk S; Van der Kooy F; Cloete T; Steenekamp J; Hamman J Biopharm Drug Dispos; 2023 Feb; 44(1):94-112. PubMed ID: 36736328 [TBL] [Abstract][Full Text] [Related]
36. Drug Delivery and Targeting to the Brain Through Nasal Route: Mechanisms, Applications and Challenges. Kashyap K; Shukla R Curr Drug Deliv; 2019; 16(10):887-901. PubMed ID: 31660815 [TBL] [Abstract][Full Text] [Related]
37. Formulation and physiological factors influencing CNS delivery upon intranasal administration. Vyas TK; Tiwari SB; Amiji MM Crit Rev Ther Drug Carrier Syst; 2006; 23(4):319-47. PubMed ID: 17341201 [TBL] [Abstract][Full Text] [Related]
38. Intranasal Delivery of Nanoformulations: A Potential Way of Treatment for Neurological Disorders. Islam SU; Shehzad A; Ahmed MB; Lee YS Molecules; 2020 Apr; 25(8):. PubMed ID: 32326318 [TBL] [Abstract][Full Text] [Related]
39. Nasal delivery of neurotherapeutics Rajput A; Pingale P; Dhapte-Pawar V Front Pharmacol; 2022; 13():979682. PubMed ID: 36176429 [TBL] [Abstract][Full Text] [Related]
40. Advances and Challenges in Intranasal Delivery of Antipsychotic Agents Targeting the Central Nervous System. Pandey M; Jain N; Kanoujia J; Hussain Z; Gorain B Front Pharmacol; 2022; 13():865590. PubMed ID: 35401164 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]